Insiders · Profile

Fromkin Andrew J.

Director at Immunovant. Filing since 10 Aug 2021. CIK 0001341896

Company

Date

Role

Action

Shares

Amount

Of holding

IMVT Immunovant, Inc.

28 May 2026

Director

Sold at will

221,951

$7.44M

74.9%

IMVT Immunovant, Inc.

1 Dec 2025

Director

Sold on a plan

22,249

$517.19K

20.6%

IMVT Immunovant, Inc.

7 Mar 2025

Director

Sold on a plan

8,000

$156.77K

8.0%

IMVT Immunovant, Inc.

1 Dec 2023

Director

Sold on a plan

12,350

$490.70K

12.2%

IMVT Immunovant, Inc.

10 Aug 2021

Director

Bought

5,500

$43.45K

13.7%

5 decisions on file.